LATE-BREAKING ABSTRACT: Differences in S. pneumoniae serotypes distribution causing CAP in hospitalized adults in Spain according to comorbidities by a new urinary antigen detection (UAD) test. The CAPA study Rosario Menendez Villanueva (Valencia, Spain), Rosario Menéndez, Antoni Torres, Pedro Pablo España, Emilio Pérez-Trallero, José Luis López Hontangas, Francesc Marco, Ana Patricia Martínez de la Fuente, José María Marimón, Alexandra Gimeno, Catia Cilloniz, Ane Uranga, María Ercibengoa, César Balseiro, Cristina Méndez, Isabel Cifuentes
Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants
Disease area: Respiratory infectionsRating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Rosario Menendez Villanueva (Valencia, Spain), Rosario Menéndez, Antoni Torres, Pedro Pablo España, Emilio Pérez-Trallero, José Luis López Hontangas, Francesc Marco, Ana Patricia Martínez de la Fuente, José María Marimón, Alexandra Gimeno, Catia Cilloniz, Ane Uranga, María Ercibengoa, César Balseiro, Cristina Méndez, Isabel Cifuentes. LATE-BREAKING ABSTRACT: Differences in S. pneumoniae serotypes distribution causing CAP in hospitalized adults in Spain according to comorbidities by a new urinary antigen detection (UAD) test. The CAPA study. Eur Respir J 2015; 46: Suppl. 59, 2581
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
LATE-BREAKING ABSTRACT: Pneumococcal serotypes causing community-acquired pneumonia (CAP) among hospitalized adults in Spain using a new urinary antigen detection (UAD) test. The CAPA study Source: International Congress 2014 – New technologies and biomarkers in lung disease Year: 2014
Incidence of hospitalized all-cause pneumonia, and serotype distribution of hospitalized streptococcus pneumoniae pneumonia in Norway 2008-2009 Source: Annual Congress 2013 –Epidemiology of respiratory disease Year: 2013
Risk of hospitalization due to pneumococcal pneumonia in adults in Spain. The CORIENNE study Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015
Community-acquired pneumonia (CAP) caused by mycoplasma pneumoniae or chlamydophila pneumoniae in children: Are there reliable signs/symptoms for clinical diagnostics? Source: Annual Congress 2013 –The burden of respiratory infections in children Year: 2013
Role of viruses, alone and in association with bacteria, in adults hospitalized with community-acquired pneumonia (CAP) Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia Year: 2011
Mycoplasma pneumoniae infections in a paediatric setting; changes in epidemiology and clinical presentationSource: Annual Congress 2013 –The burden of respiratory infections in children Year: 2013
Pneumococcal carriage and serotypes distribution in patients with acute otitis media in Switzerland, 2004-2014 Source: International Congress 2016 – Epidemiological aspects of tuberculosis and other respiratory conditions: from lung cancer to late-onset Pompe's disease Year: 2016
Use of pneumonia severity index in Spain to decide hospitalization among patients with community-acquired pneumonia (CAP). (Nacar Study) Source: Eur Respir J 2005; 26: Suppl. 49, 637s Year: 2005
Influence of comorbidities in the clinical presentation of invasive pneumococcal disease (IPD) in adults in Spain, 2010-2013. The ODIN study Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer Year: 2014
Increasing prevalence of complicated pneumonia and pneumococcal related hemolytic uremic syndrome despite territory-wide program of pneumococcal conjugated vaccination (PCV-7) program in children Source: International Congress 2014 – Paediatric epidemiology: wheeze, asthma and other respiratory diseases Year: 2014
Pneumococcal serotypes in adult lower respiratory tract infections in primary care in Belgium Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer Year: 2014
Community-acquired pneumonia trough enterobacteriaceae and p. aeruginosa : diagnosis, incidence, and predictors. The German CAPNETZ Source: Annual Congress 2009 - Respiratory infection caused by Pseudomonas aeruginosa Year: 2009
Clinical cure rates and infection types in the MOxifloxacin Treatment IV (MOTIV) study in hospitalized patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2006; 28: Suppl. 50, 349s Year: 2006
Pneumococcal urinary antigen test use in diagnosis and treatment of pneumonia in seven Utah hospitals Source: ERJ Open Res, 2 (4) 00011-2016; 10.1183/23120541.00011-2016 Year: 2016
Carbapenemase producing Klebsiella pneumoniae (KPC+) colonization/infection in a respiratory intensive care unit: Prevalence, length of stay(LOS) and mortality Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014
LATE-BREAKING ABSTRACT: Clinical profile of adult patients with invasive pneumococcal disease (IPD) during a 3 year surveillance in Belgium Source: Annual Congress 2012 - COPD epidemiology Year: 2012
Mortality directly related to community-acquired pneumonia (CAP) in hospitalized patients: results from the community-acquired pneumonia organization (CAPO) international cohort study Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia Year: 2007
Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults Source: Eur Respir J 2003; 21: 209-214 Year: 2003
Clinical features of adults with seven-valent- conjugated-vaccine- serotype pneumococcal pneumonia Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013
Antibiotic resistance genotype trend and association with host clinical characteristics in respiratory isolates of streptococcus pneumoniae Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014